Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer

Annals of Surgical Oncology

Volumn 17, Issue 12, 2010, Pages 3187-3194

  Bollschweiler, Elfriede ^a   Besch, Sarah ^a   Drebber, Uta ^a   Schröder, Wolfgang ^a   Mönig, Stefan P ^a   Vallböhmer, Daniel ^a   Baldus, Stephan E ^b   Metzger, Ralf ^a   Hölscher, Arnulf H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; RADIATION DOSE; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 78650973936     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1196-8     Document Type: Article

References (30)

1. M Stahl M Walz M Stuschke N Lehmann HJ Meyer J Riera-Knorrenschild, et al. 2009 Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 851 856 1:CAS:528:DC%2BD1MXjs1Kntrw%3D 10.1200/JCO.2008.17.0506 19139439
2. J Tepper M Krasna D Niedzwiecki D Hollis CE Reed R Goldberg, et al. 2008 Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 1086 1092 1:CAS:528:DC%2BD1cXktVKitr0%3D 10.1200/JCO.2007.12.9593 18309943
3. DJ Adelstein TW Rice LA Rybicki JP Saxton GM Videtic SC Murthy, et al. 2007 A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction-the impact of clinical heterogeneity Am J Clin Oncol 30 172 180 1:CAS:528:DC%2BD2sXltFWjsbo%3D 10.1097/01.coc.0000251243.58048.12 17414467 (Pubitemid 46573253)
4. E Bollschweiler R Metzger U Drebber S Baldus D Vallböhmer M Kocher, et al. 2009 Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis Ann Oncol 20 231 238 1:STN:280:DC%2BD1M7jtlWlsQ%3D%3D 10.1093/annonc/mdn622 18836090
5. P Schneider S Baldus R Metzger M Kocher R Bongartz E Bollschweiler, et al. 2005 Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification Ann Surg 242 684 692 10.1097/01.sla.0000186170.38348.7b 16244542 (Pubitemid 41567124)
6. C Mariette G Piessen N Briez J Triboulet 2008 The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg 247 365 371 10.1097/SLA.0b013e31815aaadf 18216546 (Pubitemid 351156783)
7. K Prenzel A Konig P Schneider C Schnickmann SE Baldus W Schroder, et al. 2007 Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer Ann Surg Oncol 14 954 959 10.1245/s10434-006-9141-6 17103071 (Pubitemid 46175347)
8. TN Walsh N Noonan D Hollywood A Kelly N Keeling TPJ Hennessy 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma New Engl J Med 335 462 467 1:STN:280:DyaK283psF2juw%3D%3D 10.1056/ NEJM199608153350702 8672151 (Pubitemid 26269945)
9. I Rouvelas W Zeng M Lindblad P Viklund W Ye J Lagergren 2006 Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study World J Surg 30 2182 2190 10.1007/s00268-006-0016-6 17006610 discussion 2191-2 (Pubitemid 44885173)
10. T Read J Andujar P Caushaj DR Johnston DW Dietz RJ Myerson, et al. 2004 Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status Dis Colon Rectum 47 825 831 10.1007/s10350-004-0535-x 15108025 (Pubitemid 38702600)
11. R Stupp M Mayer R Kann W Weder A Zouhair DC Betticher, et al. 2009 Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial Lancet Oncol 10 785 793 1:CAS:528:DC%2BD1MXptlals7w%3D 10.1016/S1470-2045(09)70172-X 19604722
12. W Schröder S Baldus S Monig T Beckurts H Dienes A Hölscher 2002 Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis World J Surg 26 584 587 10.1007/s00268-001-0271-5 12098049 (Pubitemid 36920370)
13. Sobin L, Wittekind C. UICC (2002) TNM Classification of Malignant Tumors. 6th ed. New York: Wiley & Sons, 2002.
14. A Hölscher W Schroder E Bollschweiler K Beckurts P Schneider 2003 How safe is high intrathoracic esophagogastrostomy? Chirurg 74 726 733 10.1007/s00104-003-0649-z 12928793 (Pubitemid 38270145)
15. S Baldus S Monig W Schroder R Metzger S Lang TK Zirbes, et al. 2004 Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation Pathologe 25 421 427 1:STN:280:DC%2BD2M%2FivV2mtA%3D%3D 10.1007/s00292-004-0697-2 15168076 (Pubitemid 40022464)
16. M Wichmann C Muller G Meyer T Strauss HM Hornung U Lau-Werner, et al. 2002 Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer Arch Surg 137 206 210 10.1001/archsurg.137.2.206 11822961 (Pubitemid 34142139)
17. K Maschuw R Kress A Ramaswamy I Braun P Langer B Gerdes 2006 Short-term preoperative radiotherapy in rectal cancer patients leads to a reduction of the detectable number of lymph nodes in resection specimens Langenbecks Arch Surg 391 364 368 1:STN:280:DC%2BD28nmvVSgtQ%3D%3D 10.1007/s00423-006-0056-2 16683146 (Pubitemid 44298428)
18. P Taflampas M Christodoulakis S Gourtsoyianni K Leventi J Melissas D Tsiftsis 2009 The effect of preoperative chemoradiotherapy on lymph node harvest after total mesorectal excision for rectal cancer Dis Colon Rectum 52 1470 1474 19617762
19. R Perez D Pereira I Proscurshim J Gama-Rodrigues V Rawet GP São Julião D Kiss I Cecconello A Habr-Gama, et al. 2009 Lymph node size in rectal cancer following neoadjuvant chemoradiation-can we rely on radiologic nodal staging after chemoradiation? Dis Colon Rectum 52 1278 1284 19571705
20. C Twine W Lewis M Morgan D Chan GW Clark T Havard, et al. 2009 The assessment of prognosis of surgically resected oesophageal cancer is dependent on the number of lymph nodes examined pathologically Histopathology 55 46 52 10.1111/j.1365-2559.2009.03332.x 19614766
21. A Greenstein V Litle S Swanson C Divino S Packer J Wisnivesky 2008 Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer Cancer 112 1239 1246 10.1002/cncr.23309 18224663 (Pubitemid 351429738)
22. M Wilson E Rosato K Chojnacki I Chervoneva JC Kairys HE Cohn, et al. 2008 Prognostic significance of lymph node metastases and ratio in esophageal cancer J Surg Res 146 11 15 10.1016/j.jss.2007.07.028 18028955 (Pubitemid 351442944)
23. C Peyre J Hagen MS De NK Altorki E Ancona SM Griffin, et al. 2008 The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg 248 549 556 10.1097/SLA.0b013e3181904f3c 18936567
24. N Altorki X Zhou B Stiles JL Port S Paul PC Lee, et al. 2008 Total number of resected lymph nodes predicts survival in esophageal cancer Ann Surg 248 221 226 10.1097/SLA.0b013e31817bbe59 18650631
25. A Barbour M Jones M Gonen DC Gotley J Thomas DB Thomson, et al. 2008 Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response Ann Surg Oncol 15 2894 2902 10.1245/s10434-008-0084-y 18663531
26. G Jamieson S Thompson 2009 Detection of lymph node metastases in oesophageal cancer Br J Surg 96 21 25 1:STN:280:DC%2BD1M%2Fls1OnsQ%3D%3D 10.1002/bjs.6411 19016275
27. D Adelstein T Rice M Becker MA Larto TJ Kirby A Koka, et al. 1997 Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma Cancer 80 1011 1020 1:STN:280: DyaK2svkvFagsw%3D%3D 10.1002/(SICI)1097-0142(19970915)80:6<1011::AID- CNCR2>3.0.CO;2-C 9305700 (Pubitemid 27427599)
28. P Schneider R Metzger H Schaefer F Baumgarten D Vallbohmer J Brabender, et al. 2008 Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer Ann Surg 248 902 908 10.1097/SLA.0b013e31818f3afb 19092334
29. J Leers S Ayazi J Hagen S Terterov N Klipfel A Oezcelik, et al. 2009 Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status J Am Coll Surg 208 553 556 10.1016/j.jamcollsurg.2009.01.017 19476789
30. R Metzger U Drebber SE Baldus SP Monig AH Holscher 2009 Bollschweiler E: extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus Ann Surg Oncol 16 447 453 10.1245/s10434-008- 0248-9 19037700